Statements (37)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:antibiotic
combination drug |
| gptkbp:activeIngredient |
gptkb:procaine
gptkb:penicillin_G |
| gptkbp:ATCCode |
J01CE09
|
| gptkbp:brand |
Crysticillin
Penicillin G Procaine Wycillin |
| gptkbp:CASNumber |
6130-64-9
|
| gptkbp:contraindication |
penicillin allergy
|
| gptkbp:discoveredBy |
1940s
|
| gptkbp:eliminationHalfLife |
12-24 hours
|
| gptkbp:excretion |
urine
|
| gptkbp:form |
aqueous suspension
|
| https://www.w3.org/2000/01/rdf-schema#label |
Procaine penicillin
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
inhibits bacterial cell wall synthesis
|
| gptkbp:metabolism |
renal
|
| gptkbp:otherName |
benzylpenicillin procaine
penicillin G procaine |
| gptkbp:pregnancyCategory |
B (US)
|
| gptkbp:routeOfAdministration |
intramuscular injection
|
| gptkbp:sideEffect |
allergic reaction
anaphylaxis rash pain at injection site |
| gptkbp:spectrumOfActivity |
Gram-positive bacteria
some Gram-negative bacteria |
| gptkbp:usedFor |
skin infections
syphilis anthrax bacterial infections respiratory tract infections rheumatic fever prophylaxis |
| gptkbp:WHOModelListOfEssentialMedicines |
included
|
| gptkbp:bfsParent |
gptkb:J01CF
|
| gptkbp:bfsLayer |
7
|